StockData
QTREX Quantum Ltd. logo

QTREX Quantum Ltd. (QTEX) stock

QTEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 5/30
$1.09−0.06 (-5.22%)

Close on Nov 17, 2026Market cap $39.18MP/E –Yield –

QTREX Quantum r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $7.50M, up 18.6% from the year before. The highest annual figure on record is $8.18M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.50M+18.6%
FY2024Dec 31, 2024$6.32M-13.6%
FY2023Dec 31, 2023$7.32M-10.5%
FY2022Dec 31, 2022$8.18M+101.1%
FY2021Dec 31, 2021$4.07M–

More QTREX Quantum figures

See a number that looks wrong?